Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flow provided by (used in) operating activities:
Net income	$ 511,746	$ 372,497
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization	34,093	33,536
Stock-based compensation	17,025	17,020
Income (Loss) from unconsolidated entities	9,735	(24,970)
Distributions of earnings from unconsolidated entities	30,447	29,636
Deferred tax (benefit) provision	8,646	6,797
Impairment charges and write offs	36,773	11,225
Other	2,371	2,831
Changes in operating assets and liabilities
Inventory	(299,940)	(890,202)
Origination of mortgage loans	(705,500)	(931,958)
Sale of mortgage loans	783,959	1,027,696
Receivables, prepaid expenses and other assets	4,233	(239)
Current income taxes, net	(127,199)	(14,321)
Customer deposits, net	(5,541)	110,460
Accounts payable and accrued expenses	(155,277)	45,020
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	145,571	(204,972)
Cash flow (used in) provided by investing activities:
Purchase of property, construction and office equipment - net	(39,544)	(39,140)
Investments in and advances to unconsolidated entities	(117,221)	(121,282)
Return of investments in unconsolidated entities	48,564	88,371
Proceeds from the sale of assets	9,041	0
Other	0	194
Net Cash (Used in) Provided By Investing Activities, Continuing Operations	(99,160)	(71,857)
Cash flow used in financing activities:
Proceeds from loans payable	1,652,710	1,826,068
Debt issuance costs for loans payable	(5,265)	0
Repayments of loans payable	(1,771,636)	(1,879,318)
Redemption of senior notes	(400,000)	(409,856)
(Payments) proceeds from stock-based benefit plans	28,286	(2,279)
Purchase of treasury stock	(93,089)	(284,276)
Dividends paid	(46,306)	(44,255)
Payments related to noncontrolling interests - net	0	(25,766)
Net Cash Used in Financing Activities, Continuing Operations	(635,300)	(819,682)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	(588,889)	(1,096,511)
Cash, Cash Equivalents, and Restricted Cash , beginning of period	1,398,550	1,684,412
Cash, Cash Equivalents, and Restricted Cash, end of period	$ 809,661	$ 587,901